Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

CDRH Seeks To Fill Top Policy Post As Stade Plans To Depart

This article was originally published in The Gray Sheet

  • News

Executive Summary

CDRH Deputy Center Director for Policy Nancy Stade will leave the agency at the end of the summer.

You may also be interested in...



FDA Device Center Names New Deputy Policy Director

Almost a year after Nancy Stade stepped down as deputy policy director, Lauren Silvis has been named to take on the role, which is critical to developing CDRH policy, especially as the agency is pursuing a paradigm shift in premarket data requirements.

'Acting' At CDRH: Two Top Device Offices Now Run By Interim Directors

An update on CDRH's management structure.

'Acting' At CDRH: Two Top Offices Are Now Run By Interim Directors

An update on CDRH's management structure.

Table

View full table

Related Content

Medtech Insight
Medtech Insight

Topics

Tags:
Medical Device
Latest Headlines

News We’re Watching: Free COVID-19 Tests, Edwards Antitrust Investigation, McKinsey Calls For Medtech ‘Reinvention’

Proposed Rule Would Apply FDA’s Diagnostic Rules To LDTs

Four More Guidance Documents Released: Antimicrobial Devices, Closed-Loop Control Technology, De Novo Submissions, Devices For Graft Versus Host Diseases

Minute Insight: SpectralMD Signs Another Contract With BARDA, Worth $149m

See All
UsernamePublicRestriction

Register

MT033080

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By